SCHEMBL2809624

SCHEMBL2809624

c1cnc2c(c1)ncc1ncsc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 3/20 0.39
HSD17B10 Q99714 1/20 0.39
PRMT5 O14744 1/20 0.35
MAPT P10636 3/20 0.34
LMNA P02545 3/20 0.34
HSP90AA1 P07900 2/20 0.34
CCR1 P32246 2/20 0.34
CCR8 P51685 2/20 0.34
GMNN O75496 1/20 0.34
TP53 P04637 1/20 0.34
MMP2 P08253 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MMP9 P14780 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
NFKB1 P19838 1/20 0.34
MMP8 P22894 1/20 0.34
THPO P40225 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL140968 0.74 LMNA (0.54) KDM4EALDH1A1MAPTLMNAHSP90AA1
SCHEMBL30402017 0.73 ALDH1A1 (0.47) KDM4EALDH1A1HSD17B10ALOX15SMN1; SMN2
SCHEMBL2401192 0.73 ALDH1A1 (0.47) KDM4EALDH1A1HSD17B10ALOX15SMN1; SMN2
Hydrochloric Acid SCHEMBL28958656 0.73 LMNA (0.52) KDM4EALDH1A1MAPTLMNAHSP90AA1
SCHEMBL8599120 0.73 KDM4E (0.51) KDM4EALDH1A1HSD17B10PRMT5MAPT
SCHEMBL2809627 0.73 LMNA (0.49) KDM4EALDH1A1HSD17B10MAPTLMNA
Hydrochloric Acid SCHEMBL10466114 0.72 ALDH1A1 (0.45) KDM4EALDH1A1HSD17B10SMN1; SMN2NPC1
Ammonia Solution, Strong SCHEMBL6783413 0.72 ALDH1A1 (0.45) KDM4EALDH1A1HSD17B10SMN1; SMN2NPC1
SCHEMBL2402366 0.70 KDM4E (0.45) KDM4EALDH1A1PRMT5MAPTLMNA
SCHEMBL2402419 0.70 PRMT5 (0.46) KDM4EALDH1A1HSD17B10PRMT5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378102-B2 Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-02-19 US disclosed
US-20100240693-A1 Oxime and Hydroxylamine Substituted Thiazolo [4,5-C] Ring Compounds and Methods COLEY PHARMACEUTICAL GROUP, INC (US) 2010-09-23 US disclosed
EP-1877056-A2 OXIME AND HYDROXYLAMINE SUBSTITUTED THIAZOLOÝ4,5-C¨RING COMPOUNDS AND METHODS Coley Pharmaceutical Group, Inc. (US) 2008-01-16 EP disclosed
WO-2007120121-A2 OXIME AND HYDROXYLAMINE SUBSTITUTED THIAZOLO[4,5-C] RING COMPOUNDS AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240693-A1 Oxime and Hydroxylamine Substituted Thiazolo [4,5-C] Ring Compounds and Methods IL4, IL2, TH KDM4E 1175/4885ALDH1A1 502/4885HSD17B10 896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.